S Loubiere

Summary

Country: France

Publications

  1. ncbi Economic evaluation of point-of-care diagnostic technologies for infectious diseases
    S Loubiere
    INSERM, U912 SE4S, Marseille, France
    Clin Microbiol Infect 16:1070-6. 2010
  2. ncbi Economic evaluation of ART in resource-limited countries
    Sandrine Loubiere
    INSERM IRD University of the Mediterranean UMR Economics and Social Sciences, Health Systems and Societies and Southeastern Health Regional Observatory, Marseille, France
    Curr Opin HIV AIDS 5:225-31. 2010
  3. ncbi HIV disclosure and unsafe sex among HIV-infected women in Cameroon: results from the ANRS-EVAL study
    Sandrine Loubiere
    INSERM, U912 SE4S, Marseille, France
    Soc Sci Med 69:885-91. 2009
  4. ncbi Decentralization of HIV care in Cameroon: increased access to antiretroviral treatment and associated persistent barriers
    Sandrine Loubiere
    INSERM, U912 SE4S, Marseille, France
    Health Policy 92:165-73. 2009
  5. ncbi Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116)
    Fabienne Marcellin
    INSERM, Universite Aix Marseille, Marseille, France
    AIDS Care 22:441-51. 2010
  6. ncbi Higher risk of unsafe sex and impaired quality of life among patients not receiving antiretroviral therapy in Cameroon: results from the EVAL survey (ANRS 12-116)
    Fabienne Marcellin
    INSERM, U912 SE4S, Marseille, France
    AIDS 24:S17-25. 2010
  7. ncbi Delayed first consultation after diagnosis of HIV infection in Cameroon
    Fabienne Marcellin
    INSERM U912 SE4S, ORS PACA, Observatoire Régional de la Santé Provence Alpes Côte d Azur, 23 rue Stanislas Torrents, 13006 Marseille, France
    AIDS 23:1015-9. 2009
  8. ncbi Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12-116)
    Fabienne Marcellin
    INSERM U912 ORS PACA, 23 rue Stanislas Torrents, 13006 Marseille, France
    Trop Med Int Health 13:1470-8. 2008
  9. ncbi When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience
    Sandrine Loubiere
    Health and Medical Research National Institute INSERM, Research Unit UMR 912, Marseilles, France
    Antivir Ther 13:241-51. 2008
  10. ncbi Including polymerase chain reaction in screening for hepatitis C virus RNA in blood donations is not cost-effective
    S Loubiere
    Institut National de la Santé et de la Recherche Médicale INSERM U379, Marseille, France
    Vox Sang 80:199-204. 2001

Detail Information

Publications10

  1. ncbi Economic evaluation of point-of-care diagnostic technologies for infectious diseases
    S Loubiere
    INSERM, U912 SE4S, Marseille, France
    Clin Microbiol Infect 16:1070-6. 2010
    ....
  2. ncbi Economic evaluation of ART in resource-limited countries
    Sandrine Loubiere
    INSERM IRD University of the Mediterranean UMR Economics and Social Sciences, Health Systems and Societies and Southeastern Health Regional Observatory, Marseille, France
    Curr Opin HIV AIDS 5:225-31. 2010
    ..We focus on studies that evaluate when to start therapy, what therapy to start with and what to switch to based on what criteria...
  3. ncbi HIV disclosure and unsafe sex among HIV-infected women in Cameroon: results from the ANRS-EVAL study
    Sandrine Loubiere
    INSERM, U912 SE4S, Marseille, France
    Soc Sci Med 69:885-91. 2009
    ..On the contrary, beliefs overestimating the effectiveness of antiretroviral therapies were quite widespread among respondents and predictive of both concealment of HIV status and unsafe sex...
  4. ncbi Decentralization of HIV care in Cameroon: increased access to antiretroviral treatment and associated persistent barriers
    Sandrine Loubiere
    INSERM, U912 SE4S, Marseille, France
    Health Policy 92:165-73. 2009
    ..The national antiretroviral treatment (ART) program in Cameroon has reached one of the highest rate of coverage in Western and Central Africa (58% of the estimated eligible HIV-infected population in June 2008)...
  5. ncbi Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116)
    Fabienne Marcellin
    INSERM, Universite Aix Marseille, Marseille, France
    AIDS Care 22:441-51. 2010
    ..7 [1.2-2.4]). As a conclusion, the desire to have a child is frequent among ART-treated WLHA in Cameroon. HIV care and family planning programs should be integrated more thoroughly in order to support WLHA's reproductive choices...
  6. ncbi Higher risk of unsafe sex and impaired quality of life among patients not receiving antiretroviral therapy in Cameroon: results from the EVAL survey (ANRS 12-116)
    Fabienne Marcellin
    INSERM, U912 SE4S, Marseille, France
    AIDS 24:S17-25. 2010
    ..Current clinical research suggests these criteria may be too stringent. This study aimed at evaluating the effect of not receiving ART on patients' psychosocial outcomes...
  7. ncbi Delayed first consultation after diagnosis of HIV infection in Cameroon
    Fabienne Marcellin
    INSERM U912 SE4S, ORS PACA, Observatoire Régional de la Santé Provence Alpes Côte d Azur, 23 rue Stanislas Torrents, 13006 Marseille, France
    AIDS 23:1015-9. 2009
    ..To study the impact of both decentralization of HIV care and individual factors on delayed first consultation (> or =6 months) after HIV diagnosis in Cameroon, in the context of the national antiretroviral treatment scale-up program...
  8. ncbi Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12-116)
    Fabienne Marcellin
    INSERM U912 ORS PACA, 23 rue Stanislas Torrents, 13006 Marseille, France
    Trop Med Int Health 13:1470-8. 2008
    ..To identify correlates of self-reported antiretroviral therapies (ART) interruptions among people living with HIV and AIDS (PLWHA) in Cameroon...
  9. ncbi When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience
    Sandrine Loubiere
    Health and Medical Research National Institute INSERM, Research Unit UMR 912, Marseilles, France
    Antivir Ther 13:241-51. 2008
    ....
  10. ncbi Including polymerase chain reaction in screening for hepatitis C virus RNA in blood donations is not cost-effective
    S Loubiere
    Institut National de la Santé et de la Recherche Médicale INSERM U379, Marseille, France
    Vox Sang 80:199-204. 2001
    ..To assess the cost and effectiveness of adding a system of polymerase chain reaction (PCR) testing to the current enzyme-linked immunosorbent assay (ELISA) screening for hepatitis C virus (HCV) in blood donations...